The habit of putting handcuffs on human embryonic stem cell research might soon become a thing of the past, two news items point out today. Federal lawmakers want to get rid of three patents related to human embryonic stem cells, which could ease restrictions on future commercialization.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.